OncoDNA is a Belgium-based company founded in December 2012 focusing on precision medicine in oncology. The company aims to provide cancer molecular profiling to individualize therapy decisions. In September 2016, OncoDNA raised EUR 7.7 million in private equity. The new shares were subscribed by both the historical shareholders (IPG/bio.be, Invest4OncoDNA, Sambrinvest, and Vinsovier) as well as a group of four new investors (Sofinim NV, an affiliate of

Ackermans & van Haaren Ackermans & van Haaren (often abbreviated as AvH) is a diversified group active in: Marine Engineering & Contracting (DEME, one of the largest dredging companies in the world - CFE, a construction group with headquarters in Belgium), Private Banki ...

, SRIW, CPH, and Inventures). In 2015, the company was recognized by Ernst & Young in Belgium as the "Promising Enterprise of the Year," a category in their "Entrepreneurs of the Year" awards. The company was also awarded Most Disruptive Innovator of 2015 by Deloitte’s Fast 50 jury. In April 2014, OncoDNA was selected for the multi-year analysis research program AURORA conducted by BIG, that aims to significantly improve the life of patients with metastatic or locally relapsed breast cancer. The project, which focuses on both the development of treatments targeting specific molecular aberrations and a better understanding of

metastatic disease Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, ...

, will use OncoDEEP to perform cancer related targeted

gene sequencing Gene Sequencing may refer to: * DNA sequencing * or a comprehensive variant of it: Whole genome sequencing Whole genome sequencing (WGS), also known as full genome sequencing, complete genome sequencing, or entire genome sequencing, is the pro ...

. Initially, 1300 women and men treated in about 60 hospitals spread across 15 European countries are expected to take part in AURORA.

François Blondel François Blondel ( June 1618 – 21 January 1686) was a soldier, engineer of fortifications, mathematician, diplomat, military and civil engineer and architect, called "the Great Blondel", to distinguish him in a dynasty of French architects. ...

sits on the board of directors of OncoDNA.

References

{{Reflist Medical technology companies of Belgium Belgian brands Belgian companies established in 2012